Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation
Authors
Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford
President, European Society of Cardiology, 2nd Medical Department with Cardiology and Intensive Care Medicine, Klinik Landstrasse, Vienna
Michelle A. Albert
President, American Heart Association. Walter A. Haas-Lucie Stern Endowed Chair in Cardiology and Admissions Dean, University of California San Francisco Medical School. Director, CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Center), San Francisco, CA
Edward T. A. Fry
President, American College of Cardiology, Washington, DC; Chair, Ascension Health Cardiovascular Service Line, Indianapolis, IN
President, World Heart Federation, Geneva, CH; Department of Cardiology, Santa Maria University Hospital, CHULN E.P.E., CCUL, University of Lisbon, Lisbon
For the Clinical Trial Expert Group and ESC Patient Forum
DOI: https://doi.org/10.5334/gh.1178 | Journal eISSN: 2211-8179
Language: English
Submitted on: Sep 20, 2022
Accepted on: Nov 3, 2022
Published on: Dec 16, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2022 Louise Bowman, Franz Weidinger, Michelle A. Albert, Edward T. A. Fry, Fausto J. Pinto, For the Clinical Trial Expert Group and ESC Patient Forum, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.